• HBM Holdings named immunology and immuno-oncology executive Luisa Salter-Cid as scientific advisor on June 10, 2026.
• Salter-Cid is a venture partner at Osage University Partners.
• She previously served as chief scientific officer of Pioneering Medicines at Flagship Pioneering.
• Earlier roles include chief scientific officer at Gossamer Bio.
• She spent 13 years at Bristol Myers Squibb, most recently as vice president leading immunology, small molecule immuno-oncology, and genomics discovery.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HBM Holdings Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202606102152PR_NEWS_USPR_____CN81334) on June 11, 2026, and is solely responsible for the information contained therein.